
Nidan Laboratories & Healthcare Ltd: Valuation Shifts Signal Renewed Price Attractiveness
2026-05-27 08:01:56Nidan Laboratories & Healthcare Ltd has witnessed a notable shift in its valuation parameters, moving from a risky to an attractive territory, despite ongoing operational challenges and a micro-cap status. This recalibration in price-to-earnings (P/E) and price-to-book value (P/BV) ratios relative to historical and peer averages offers investors a fresh perspective on the stock’s price attractiveness amid a difficult market backdrop.
Read full news articleNo announcement available
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






